| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $2,303,382 ) |
| 2024 | 2024 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST | LIVERMORE | CA | 94550-3153 | ALAMEDA | USA | R24GM137748 | National User Resource for Biological Accelerator Mass Spectrometry | 000 | 5 | NIH | 9/4/2024 | $1,206,711 |
| 2024 | 2024 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST | LIVERMORE | CA | 94550-3153 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 9 | NIH | 5/10/2024 | $526,300 |
| 2024 | 2024 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST | LIVERMORE | CA | 94550-3153 | ALAMEDA | USA | R33HL159947 | Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology | 002 | 4 | NIH | 9/6/2024 | $570,371 |
| 2024 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST | LIVERMORE | CA | 94550-3153 | ALAMEDA | USA | U19AI144184 | Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis | 000 | 5 | NIH | 4/24/2024 | $0 |
| 2024 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST | LIVERMORE | CA | 94550-3153 | ALAMEDA | USA | R33HL159947 | Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology | 001 | 3 | NIH | 9/5/2024 | $0 |
| 2024 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST | LIVERMORE | CA | 94550-3153 | ALAMEDA | USA | U19AI144184 | Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis | 001 | 5 | NIH | 6/10/2024 | $0 |
| 2024 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R33HL159947 | Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology | 000 | 3 | NIH | 3/19/2024 | $381,835 |
| 2024 | 2022 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 1ST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R61HL159947 | Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology | 000 | 2 | NIH | 3/19/2024 | -$381,835 |
|
 | Issue Date FY: 2023 ( Subtotal = $4,464,310 ) |
| 2023 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | U19AI144184 | Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis | 001 | 5 | NIH | 8/3/2023 | $1,878,172 |
| 2023 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R33HL159947 | Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology | 000 | 3 | NIH | 9/13/2023 | $608,177 |
| 2023 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 8 | NIH | 5/9/2023 | $525,739 |
| 2023 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R24GM137748 | National User Resource for Biological Accelerator Mass Spectrometry | 001 | 4 | NIH | 9/18/2023 | $245,511 |
| 2023 | 2023 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R24GM137748 | National User Resource for Biological Accelerator Mass Spectrometry | 000 | 4 | NIH | 9/15/2023 | $1,206,711 |
| 2023 | 2022 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | U19AI144184 | Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis | 000 | 4 | NIH | 3/16/2023 | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $4,626,859 ) |
| 2022 | 2022 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | U19AI144184 | Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis | 001 | 4 | NIH | 8/31/2022 | $1,916,780 |
| 2022 | 2022 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R61HL159947 | Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology | 000 | 2 | NIH | 9/5/2022 | $978,033 |
| 2022 | 2022 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 002 | 7 | NIH | 6/28/2022 | $525,335 |
| 2022 | 2022 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R24GM137748 | National User Resource for Biological Accelerator Mass Spectrometry | 000 | 3 | NIH | 8/26/2022 | $1,206,711 |
| 2022 | 2021 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 001 | 6 | NIH | 4/1/2022 | $112,600 |
| 2022 | 2020 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 5 | NIH | 4/1/2022 | -$112,600 |
|
 | Issue Date FY: 2021 ( Subtotal = $2,733,567 ) |
| 2021 | 2021 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R61HL159947 | Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology | 000 | 1 | NIH | 9/14/2021 | $981,821 |
| 2021 | 2021 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 001 | 6 | NIH | 5/13/2021 | $532,873 |
| 2021 | 2021 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R24GM137748 | National User Resource for Biological Accelerator Mass Spectrometry | 000 | 2 | NIH | 8/17/2021 | $1,218,873 |
| 2021 | 2020 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 5 | NIH | 5/13/2021 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = $1,946,942 ) |
| 2020 | 2020 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R24GM137748 | National User Resource for Biological Accelerator Mass Spectrometry | 000 | 1 | NIH | 8/14/2020 | $1,406,025 |
| 2020 | 2020 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 5 | NIH | 4/1/2020 | $541,329 |
| 2020 | 2017 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R21AI120925 | Synthetic Generation of a Chlamydia Vaccine | 002 | 2 | NIH | 4/3/2020 | -$412 |
| 2020 | 2017 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R21AI120925 | Synthetic Generation of a Chlamydia Vaccine | 001 | 2 | NIH | 4/3/2020 | $652 |
| 2020 | 2017 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R21AI120925 | Synthetic Generation of a Chlamydia Vaccine | 000 | 2 | NIH | 2/27/2020 | -$652 |
|
 | Issue Date FY: 2019 ( Subtotal = $536,721 ) |
| 2019 | 2019 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 7000 EAST AVE | LIVERMORE | CA | 94550-9698 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 4 | NIH | 2/9/2019 | $536,721 |
| 2019 | 2016 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-3141 | ALAMEDA | USA | R56DK110145 | The Role of Mef2C in Bone | 000 | 1 | NIH | 1/17/2019 | $0 |
|
 | Issue Date FY: 2018 ( Subtotal = $535,786 ) |
| 2018 | 2018 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-6010 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 001 | 3 | NIH | 5/10/2018 | $53,580 |
| 2018 | 2018 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-6010 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 3 | NIH | 2/3/2018 | $482,206 |
|
 | Issue Date FY: 2017 ( Subtotal = $219,158 ) |
| 2017 | 2017 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-6010 | ALAMEDA | USA | R21AI120925 | Synthetic Generation of a Chlamydia Vaccine | 000 | 2 | NIH | 6/22/2017 | $219,158 |
|
 | Issue Date FY: 2016 ( Subtotal = $946,969 ) |
| 2016 | 2016 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-6010 | ALAMEDA | USA | R01GM117342 | Technology Development for Biological Imaging with XFELs | 000 | 1 | NIH | 4/28/2016 | $533,280 |
| 2016 | 2016 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-6010 | ALAMEDA | USA | R56DK110145 | The Role of Mef2C in Bone | 000 | 1 | NIH | 7/28/2016 | $147,424 |
| 2016 | 2016 | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2300 FIRST ST STE 204 | LIVERMORE | CA | 94550-6010 | ALAMEDA | USA | R21AI120925 | Synthetic Generation of a Chlamydia Vaccine | 000 | 1 | NIH | 6/30/2016 | $266,265 |
|
|